IDSA has developed a COVID-19 antibody testing primer for policymakers, scientists, and clinicians to drive research and appropriate use of serologic testing. At this time, more evidence is needed before implementing and expanding these tests for clinical and public health use.
IDSA and HIVMA warned today that prematurely easing social distancing measures put in place to curtail the spread of COVID-19 will risk increased infections and deaths, incapacitated health care facilities, and prolonged economic hardships.
The unprecedented public health crisis of the COVID-19 pandemic demands a comprehensive international response. President Trump’s announcement Tuesday that he will suspend funding to the WHO is against all of our best interests.
An expert panel of infectious diseases clinicians, pharmacists and other specialists convened by the Infectious Diseases Society of America has released guidelines for treatment and management of patients with COVID-19.
IDSA and HIVMA welcome the president's extension of his projected duration for stay-at-home and physical distancing guidelines to last at least through April based on public health guidance, while calling for continued commitment to data-driven responses to the coronavirus.
The Infectious Diseases Society of America commends March 24 action by the U.S. Food and Drug Administration to open access through its emergency Investigational Drug Applications to treatment with COVID-19 convalescent plasma for patients suffering severe or life-threatening impacts of the disease.
As infectious diseases and HIV specialists and other health workers confronting the mounting challenges of COVID-19 without a vaccine, proven treatment and adequate diagnostic tools, we are troubled by President Trump’s suggestions that restrictions on gathering and travel may be lifted soon, or before an arbitrary date.
In the midst of the new global health threat posed by COVID-19, this World TB Day reminds us that global efforts to control the world’s leading infectious disease killer must be accelerated to rid us of our oldest pandemic.
Infectious disease and HIV physicians, healthcare epidemiologists and other medical professionals on the frontlines defending our country from COVID-19 urgently need equipment and supplies to protect themselves, identify infections, treat patients, and save lives.
With attention to diagnostic, treatment, health care and community needs that must be met if we are to reverse the trajectory of COVID-19 spread in the United States, the Coronavirus Aid, Relief, and Economic Security Act addresses some of the most critical challenges facing our country in the weeks and months ahead.
The Infectious Diseases Society of America has developed recommendations for public health and health care professionals to prioritize testing for COVID-19 during the shortage of accessible tests and the continuing spread of the virus.
The Infectious Diseases Society of America and its HIV Medicine Association endorse the measures to control the spread of COVID-19 called for by the Trump administration Monday.